210 related articles for article (PubMed ID: 23290982)
1. The incidence of acute anterior uveitis after intravenous zoledronate.
Patel DV; Horne A; House M; Reid IR; McGhee CN
Ophthalmology; 2013 Apr; 120(4):773-6. PubMed ID: 23290982
[TBL] [Abstract][Full Text] [Related]
2. Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.
Patel DV; Bolland M; Nisa Z; Al-Abuwsi F; Singh M; Horne A; Reid IR; McGhee CN
Osteoporos Int; 2015 Feb; 26(2):499-503. PubMed ID: 25187119
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate.
Patel DV; Horne A; Mihov B; Stewart A; Reid IR; McGhee CN
Calcif Tissue Int; 2015 Jul; 97(1):58-61. PubMed ID: 26001948
[TBL] [Abstract][Full Text] [Related]
4. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
Umunakwe OC; Herren D; Kim SJ; Kohanim S
Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
[TBL] [Abstract][Full Text] [Related]
5. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
6. Anterior uveitis complicating zoledronic acid infusion.
Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
[TBL] [Abstract][Full Text] [Related]
7. The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.
Grey A; Bolland MJ; Wattie D; Horne A; Gamble G; Reid IR
J Clin Endocrinol Metab; 2009 Feb; 94(2):538-44. PubMed ID: 19050050
[TBL] [Abstract][Full Text] [Related]
8. Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
Belliveau MJ; Almeida DR; Urton TE
Can J Ophthalmol; 2012 Oct; 47(5):e22-3. PubMed ID: 23036555
[No Abstract] [Full Text] [Related]
9. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
[TBL] [Abstract][Full Text] [Related]
10. The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.
Anastasilakis AD; Polyzos SA; Delaroudis S; Bisbinas I; Sakellariou GT; Gkiomisi A; Papadopoulou E; Gerou S; Makras P
Clin Endocrinol (Oxf); 2012 Dec; 77(6):816-22. PubMed ID: 22676573
[TBL] [Abstract][Full Text] [Related]
11. Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
Grey A; Bolland MJ; Horne A; Wattie D; House M; Gamble G; Reid IR
Bone; 2012 Jun; 50(6):1389-93. PubMed ID: 22465268
[TBL] [Abstract][Full Text] [Related]
12. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
El Saghir NS; Otrock ZK; Bleik JH
BMC Cancer; 2005 Dec; 5():156. PubMed ID: 16332258
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
Chatterjee S; Agrawal D
J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
15. Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature.
Jin X; Shou Z; Shao Y; Bian P
Arch Osteoporos; 2021 Jun; 16(1):104. PubMed ID: 34180015
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis.
Hedayatfar A; Hashemi H; Asgari S; Chee SP
Cornea; 2014 Apr; 33(4):366-72. PubMed ID: 24351572
[TBL] [Abstract][Full Text] [Related]
17. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
Jun JH
Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
[No Abstract] [Full Text] [Related]
18. No effect of rosuvastatin in the zoledronate-induced acute-phase response.
Makras P; Anastasilakis AD; Polyzos SA; Bisbinas I; Sakellariou GT; Papapoulos SE
Calcif Tissue Int; 2011 May; 88(5):402-8. PubMed ID: 21305270
[TBL] [Abstract][Full Text] [Related]
19. Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
Ramasamy B; Quah S; Sahni JN; Palimar P
J Ocul Pharmacol Ther; 2007 Oct; 23(5):513-5. PubMed ID: 17900233
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
Popp AW; Senn R; Curkovic I; Senn C; Buffat H; Popp PF; Lippuner K
Osteoporos Int; 2017 Jun; 28(6):1995-2002. PubMed ID: 28299378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
